Key Market Indicators
The country came in number 9 in 2021, Ireland overtook at $561,370,000. Germany, France and Italy respectively were numbers 2, 3 and 4 in this ranking. Sales of antiinfective medicine in Belgium is projected to reach $863 million by 2026, up 0.9% annually from 2021's total of $830 million. Since 2007, Belgium's market has grown 3.4% year on year. Greece overtook Belgium in 2021, with a total of $830 million, while Germany, South Korea and Italy came in second, third and fourth, respectively. Belgium's antibiotic exports are projected to reach $579 million by 2026, down 0.7% year on year on average. Since 2004, the country's supply has declined 1.7% annually. India overtook Belgium in 2021, with $613 million, while Switzerland, Italy and India were second, third and fourth, respectively. Belgium's antibiotic imports are estimated to reach $524 million by 2026, down 0.8% year on year on average. Since 2004, the country's demand has been decreasing 3.6% annually. Ireland overtook Belgium in 2021, with a total of $561 million, while Germany, France and Italy were second, third and fourth, respectively.
